Platform

One platform for drug and RNA discovery.

BrainOmega's foundation models power two products, Drug Discovery and RNA Discovery, behind one sign-in. Generate candidates, evaluate them on the properties that matter and prioritise them for the lab, with the evidence for every result shown beside it.

Two products
Drug Discovery and RNA Discovery
Own models
foundation models built in-house
Evidence
sources shown beside every result
Reproducible
same input, same answer
What is inside

One system, not a stack of point tools.

Three parts that work together to take a research question to a shortlist your team can defend.

Foundation Model

Models built and trained by BrainOmega for chemistry and RNA biology. They generate candidates and predict the properties that decide which go forward.

  • Generation of molecules and sequences
  • Property prediction, including ADMET
  • A confidence for every prediction

Drug Discovery

A Generative AI workspace for small-molecule programmes, from target to shortlist.

  • Identify and assess targets
  • Design and explore molecules in 3D
  • Prioritise candidates for further testing

RNA Discovery

Discovery across RNA classes, from microRNAs and tRNA fragments to circular RNAs and mRNA neoantigens.

  • Characterise a sequence you already have
  • Scan public data for new candidates
  • The rule and evidence behind every verdict
How it works

From a research question to a shortlist you can defend.

Four steps your team can adopt without rebuilding its existing stack.

Frame the question

Set the target, the modality and the constraints that matter to your programme.

Generate

Our models propose candidate molecules or RNA sequences that fit the brief.

Evaluate

Each candidate is scored on the properties that decide its fate, with evidence and confidence shown.

Prioritise

Rank, compare and export the shortlist for your scientists and your lab.

See it on one of your own questions.

Bring a target, an RNA of interest or an existing series. We will walk your team through the platform on it, prediction by prediction.